Early real-world effectiveness of mirikizumab in a difficult-to-treat ulcerative colitis cohort. Elosua A, Zabalza L, Vicuna M, Rubio S, et al. Gastroenterol Hepatol 2026 Jul 7:502833. doi: 10.1016/j.gastrohep.2026.502833.

Read + Share

Amedeo Smart

Independent Medical Education

Elosua A, Zabalza L, Vicuna M, Rubio S, et al. Early real-world effectiveness of mirikizumab in a difficult-to-treat ulcerative colitis cohort. Gastroenterol Hepatol 2026 Jul 7:502833. doi: 10.1016/j.gastrohep.2026.502833.
PMID: 42413727